We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Endotheliopathy Assessed in COVID-19-Associated Coagulopathy

By LabMedica International staff writers
Posted on 23 Jul 2020
An important feature of severe acute respiratory syndrome coronavirus 2 pathogenesis is COVID-19-associated coagulopathy, characterized by increased thrombotic and microvascular complications. More...
COVID-19 infection coagulopathy is characterized by high D-dimer and fibrinogen concentrations with minor changes in prothrombin time and platelet count.

The disease consists of an early infectious phase in which the virus enters pulmonary epithelial cells via surface angiotensin-converting enzyme 2 (ACE2) receptors, causing viral pneumonia, followed by a systemic inflammatory phase characterized by respiratory failure and multiorgan dysfunction. Derangements in cytokine concentrations including interleukin-6 (IL-6) are believed to play a role in the disease.

A large team of Medical Scientists led by those at the Yale School of Medicine (New Haven, CT, USA) carried out a cross-sectional study of adult (≥18 years) patients hospitalized between April 13 and April 24, 2020, with a confirmed diagnosis of COVID-19, as measured using polymerase chain reaction (PCR) assays on nasopharyngeal swab samples. The team examined the blood of 68 patients with COVID-19. Of these patients, 48 were critically ill in an ICU. The other 20 were hospitalized, but not in the ICU.

The investigators measured D-dimer and fibrinogen using a BCS XP System (Siemens; Malvern, PA, USA). Measurements of antithrombin activity, protein C activity, protein S activity, α2-antiplasmin activity, von Willebrand factor (VWF) antigen, VWF activity, and factor VIII activity using the ACL TOP (Instrumentation Laboratory; Bedford, MA, USA). For measurements of PAI-1 and thrombin-antithrombin complexes (TAT), plasma supernatant was frozen, then sent to national Clinical Laboratory Improvement Amendments-certified reference laboratories, where testing for these analytes was done by ELISA. Soluble P-selectin, soluble CD40 ligand (sCD40L), and soluble thrombomodulin were measured also using ELISA assays.

The scientists reported that markers of endothelial cell and platelet activation were significantly elevated in ICU patients compared with non-ICU patients, including VWF antigen (mean 565% ± 199 in ICU patients versus 278% ± 133 in non-ICU patients) and soluble P-selectin (15.9 ± 4.8 ng/mL versus 11.2 ± 3.1ng/mL). VWF antigen concentrations were also elevated above the normal range in 16/20 (80%) non-ICU patients. They found mortality to be significantly correlated with VWF antigen and soluble thrombomodulin among all patients. In all patients, soluble thrombomodulin concentrations greater than 3.26 ng/mL were associated with lower rates of hospital discharge.

Alfred I. Lee, MD, PhD, an associate professor of medicine and a senior author of the study said, “Endothelial damage is a central component in the entire spectrum of COVID-19 disease. Our study is the first to demonstrate that this process of endothelial damage is present in a wide range of COVID-19 patients, particularly as people become critically ill.”

The authors concluded that endotheliopathy is present in COVID-19 and is likely to be associated with critical illness and death. Early identification of endotheliopathy and strategies to mitigate its progression might improve outcomes in COVID-19. The study was published on June 30, 2020 in the journal The Lancet Haematology.


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.